- Home
- LRMR vs TKNO Comparison
LRMR vs TKNO Comparison
Compare LRMR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- TKNO
- Stock Information
- Founded
- LRMR N/A
- TKNO 1996
- Country
- LRMR United States
- TKNO United States
- Employees
- LRMR N/A
- TKNO N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- LRMR Health Care
- TKNO Health Care
- Exchange
- LRMR Nasdaq
- TKNO Nasdaq
- Market Cap
- LRMR 332.1M
- TKNO 340.9M
- IPO Year
- LRMR N/A
- TKNO 2021
- Fundamental
- Price
- LRMR $3.45
- TKNO $4.87
- Analyst Decision
- LRMR Strong Buy
- TKNO
- Analyst Count
- LRMR 7
- TKNO 0
- Target Price
- LRMR $16.71
- TKNO N/A
- AVG Volume (30 Days)
- LRMR 1.8M
- TKNO 186.4K
- Earning Date
- LRMR 11-05-2025
- TKNO 11-06-2025
- Dividend Yield
- LRMR N/A
- TKNO N/A
- EPS Growth
- LRMR N/A
- TKNO N/A
- EPS
- LRMR N/A
- TKNO N/A
- Revenue
- LRMR N/A
- TKNO $38,923,000.00
- Revenue This Year
- LRMR N/A
- TKNO $9.52
- Revenue Next Year
- LRMR N/A
- TKNO $15.20
- P/E Ratio
- LRMR N/A
- TKNO N/A
- Revenue Growth
- LRMR N/A
- TKNO 11.40
- 52 Week Low
- LRMR $1.61
- TKNO $3.94
- 52 Week High
- LRMR $9.50
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- LRMR 39.35
- TKNO 43.67
- Support Level
- LRMR $3.16
- TKNO $4.56
- Resistance Level
- LRMR $4.50
- TKNO $5.32
- Average True Range (ATR)
- LRMR 0.30
- TKNO 0.36
- MACD
- LRMR -0.10
- TKNO -0.09
- Stochastic Oscillator
- LRMR 24.09
- TKNO 27.82
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.